Behçet’s syndrome pathophysiology and potential therapeutic targets
- 12 January 2014
- journal article
- review article
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 9 (3) , 257-265
Abstract
Behçet syndrome is a systemic inflammatory disorder characterized by multiorgan involvement such as oral and genital ulcers, uveitis, skin lesions as well as by less frequent, but often more severe, central nervous system and vascular manifestations. The pathogenetic mechanisms are still incompletely known; however the interaction between a specific genetic background and environmental or infectious factors certainly contributes to the immune dysregulation that characterizes this disease. The discovery of new immunological pathways in Behçet syndrome pathogenesis may help us to set up new treatments. In this review, we will focus our attention on the possible mechanisms underlying Behçet syndrome pathogenesis and their potential role as novel therapeutic targets.Keywords
This publication has 77 references indexed in Scilit:
- Current and future treatments for Behçet’s uveitis: road to remissionInternational Ophthalmology, 2013
- Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behçet diseaseProceedings of the National Academy of Sciences, 2013
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseasesNature Reviews Drug Discovery, 2012
- Development of Immunopathogenesis Strategies to Treat Behçet’s DiseasePathology Research International, 2012
- Clinical characteristics of neuro-Behcet’s disease in Japan: a multicenter retrospective analysisModern Rheumatology, 2011
- Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet diseaseJournal of Allergy and Clinical Immunology, 2011
- Behçet’s syndrome and micro-organismsBest Practice & Research Clinical Rheumatology, 2011
- Rituximab in intractable ocular lesions of Behcet’s disease; randomized single‐blind control study (pilot study)International Journal of Rheumatic Diseases, 2010
- Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's diseaseNature Genetics, 2010
- Phenotype and functional changes of Vγ9/Vδ2 T lymphocytes in Behçet's disease and the effect of infliximab on Vγ9/Vδ2 T cell expansion, activation and cytotoxicityArthritis Research & Therapy, 2010